Since impaired neural plasticity and neurogenesis are key mechanisms in the pathophysiology of MDD, numerous studies have reported that peripheral levels of BDNF and genetic polymorphisms of the BDNF gene are associated with the development and clinical course of MDD2, 3. This evidence concerns the gene BDNF and major depressive disorder.